Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Equity Average (2020 - 2025)

Bio Essence has reported Equity Average over the past 6 years, most recently at -$2.6 million for Q4 2025.

  • For Q4 2025, Equity Average rose 12.45% year-over-year to -$2.6 million; the TTM value through Dec 2025 reached -$2.6 million, up 12.45%, while the annual FY2025 figure was -$2.5 million, 8.91% down from the prior year.
  • Equity Average for Q4 2025 was -$2.6 million at Bio Essence, up from -$3.1 million in the prior quarter.
  • Over five years, Equity Average peaked at -$1.3 million in Q3 2023 and troughed at -$3.3 million in Q1 2023.
  • A 5-year average of -$2.4 million and a median of -$2.5 million in 2021 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: skyrocketed 55.25% in 2023 and later crashed 92.8% in 2025.
  • Year by year, Equity Average stood at -$2.4 million in 2021, then tumbled by 31.4% to -$3.1 million in 2022, then skyrocketed by 50.08% to -$1.6 million in 2023, then crashed by 89.02% to -$3.0 million in 2024, then grew by 12.45% to -$2.6 million in 2025.
  • Business Quant data shows Equity Average for BIOE at -$2.6 million in Q4 2025, -$3.1 million in Q3 2025, and -$3.1 million in Q2 2025.